Free Trial

ESAB (ESAB) Financials

ESAB logo
$91.04 +0.02 (+0.03%)
Closing price 03:59 PM Eastern
Extended Trading
$91.17 +0.13 (+0.14%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for ESAB

Annual Income Statements for ESAB

This table shows ESAB's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
157 235 224 205 265 227
Consolidated Net Income / (Loss)
160 239 228 211 271 233
Net Income / (Loss) Continuing Operations
160 239 231 223 293 259
Total Pre-Tax Income
206 319 300 319 370 328
Total Operating Income
202 306 329 404 447 412
Total Gross Profit
682 838 886 1,016 1,037 1,048
Total Revenue
1,950 2,428 2,593 2,775 2,741 2,843
Operating Revenue
1,950 2,428 2,593 2,775 2,741 2,843
Total Cost of Revenue
1,268 1,590 1,708 1,759 1,703 1,794
Operating Cost of Revenue
1,268 1,590 1,708 1,759 1,703 1,794
Total Operating Expenses
480 532 556 612 590 636
Selling, General & Admin Expense
459 513 533 587 580 608
Restructuring Charge
22 19 23 24 10 28
Other Special Charges / (Income)
0.00 - - 0.00 - 0.00
Total Other Income / (Expense), net
3.71 13 -29 -85 -77 -84
Interest Expense
-3.71 - - 85 - 84
Income Tax Expense
46 80 69 96 77 69
Net Income / (Loss) Discontinued Operations
0.00 0.00 -3.07 -12 -22 -26
Net Income / (Loss) Attributable to Noncontrolling Interest
2.45 3.57 4.27 5.74 5.91 6.47
Basic Earnings per Share
$2.62 $3.92 $3.70 $3.39 $4.36 $3.71
Weighted Average Basic Shares Outstanding
- - 60.19M 60.34M 60.53M 60.73M
Diluted Earnings per Share
$2.62 $3.92 $3.69 $3.36 $4.31 $3.67
Weighted Average Diluted Shares Outstanding
- - 60.19M 60.34M 60.53M 60.73M
Weighted Average Basic & Diluted Shares Outstanding
- - 60.19M 60.34M 60.53M 60.73M
Cash Dividends to Common per Share
- - $0.15 $0.23 $0.30 $0.38

Quarterly Income Statements for ESAB

This table shows ESAB's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/29/2023 12/31/2023 3/29/2024 6/28/2024 9/27/2024 12/31/2024 4/4/2025 7/4/2025 10/3/2025 12/31/2025 4/3/2026
Net Income / (Loss) Attributable to Common Shareholders
58 50 60 83 68 54 67 67 55 38 48
Consolidated Net Income / (Loss)
59 51 62 84 70 55 70 68 57 39 49
Net Income / (Loss) Continuing Operations
61 60 63 86 71 74 73 70 65 51 52
Total Pre-Tax Income
81 77 81 103 89 96 93 88 83 64 65
Total Operating Income
101 104 111 119 106 111 110 109 107 87 90
Total Gross Profit
250 255 255 270 254 258 255 266 269 258 275
Total Revenue
681 689 690 707 673 671 678 716 728 721 746
Operating Revenue
681 689 690 707 673 671 678 716 728 721 746
Total Cost of Revenue
431 435 435 437 419 412 423 450 459 463 470
Operating Cost of Revenue
431 435 435 437 419 412 423 450 459 463 470
Total Operating Expenses
149 151 144 151 148 147 145 157 163 171 185
Selling, General & Admin Expense
145 145 142 146 146 145 141 156 158 154 174
Restructuring Charge
3.13 6.37 1.92 4.77 1.88 1.66 4.50 1.39 4.35 18 10
Total Other Income / (Expense), net
-21 -26 -29 -16 -17 -15 -17 -21 -24 -23 -26
Interest Expense
21 26 17 16 17 - 17 21 24 23 26
Income Tax Expense
20 18 19 18 18 23 20 18 18 13 13
Net Income / (Loss) Discontinued Operations
-1.72 -8.08 -1.31 -1.16 -1.21 -19 -2.73 -1.71 -8.82 -13 -2.55
Net Income / (Loss) Attributable to Noncontrolling Interest
1.54 1.23 1.64 1.46 1.59 1.21 2.47 1.22 1.67 1.10 1.59
Basic Earnings per Share
$0.95 $0.84 $0.99 $1.36 $1.12 $0.89 $1.10 $1.10 $0.90 $0.61 $0.78
Weighted Average Basic Shares Outstanding
60.27M 60.34M 60.42M 60.44M 60.45M 60.53M 60.62M 60.70M 60.71M 60.73M 60.88M
Diluted Earnings per Share
$0.94 $0.83 $0.98 $1.35 $1.11 $0.87 $1.10 $1.09 $0.90 $0.58 $0.78
Weighted Average Diluted Shares Outstanding
60.27M 60.34M 60.42M 60.44M 60.45M 60.53M 60.62M 60.70M 60.71M 60.73M 60.88M
Weighted Average Basic & Diluted Shares Outstanding
60.27M 60.34M 60.42M 60.44M 60.45M 60.53M 60.62M 60.70M 60.71M 60.73M 60.88M
Cash Dividends to Common per Share
$0.06 - $0.06 $0.08 $0.08 - $0.08 $0.10 $0.10 - $0.10

Annual Cash Flow Statements for ESAB

This table details how cash moves in and out of ESAB's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-56 -8.00 31 30 147 -63
Net Cash From Operating Activities
309 251 214 330 355 261
Net Cash From Continuing Operating Activities
309 251 214 330 355 261
Net Income / (Loss) Continuing Operations
160 239 228 211 271 233
Consolidated Net Income / (Loss)
160 239 228 211 271 233
Depreciation Expense
77 76 66 75 67 84
Non-Cash Adjustments To Reconcile Net Income
3.07 -4.94 5.80 16 34 14
Changes in Operating Assets and Liabilities, net
70 -59 -85 29 -16 -71
Net Cash From Investing Activities
-35 -35 -184 -62 -206 -480
Net Cash From Continuing Investing Activities
-35 -35 -184 -62 -206 -480
Purchase of Property, Plant & Equipment
-40 -36 -40 -48 -52 -47
Acquisitions
0.00 -4.89 -149 -19 -154 -438
Sale of Property, Plant & Equipment
5.57 5.20 4.85 4.60 3.81 6.54
Other Investing Activities, net
- - 0.00 0.00 -4.06 -0.82
Net Cash From Financing Activities
-326 -222 7.56 -220 32 114
Net Cash From Continuing Financing Activities
-326 -222 7.56 -220 32 114
Repayment of Debt
-0.19 0.00 -592 -777 -853 -621
Payment of Dividends
-4.30 -3.71 -9.47 -17 -21 -26
Issuance of Debt
0.00 0.67 1,806 574 905 761
Effect of Exchange Rate Changes
-3.81 -1.90 -6.68 -19 -34 42
Cash Interest Paid
0.00 0.00 35 79 62 67
Cash Income Taxes Paid
0.00 0.00 86 133 95 93

Quarterly Cash Flow Statements for ESAB

This table details how cash moves in and out of ESAB's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/29/2023 12/31/2023 3/29/2024 6/28/2024 9/27/2024 12/31/2024 4/4/2025 7/4/2025 10/3/2025 12/31/2025 4/3/2026
Net Change in Cash & Equivalents
8.38 19 -26 152 25 -4.31 42 -33 -40 -32 819
Net Cash From Operating Activities
107 122 44 83 101 127 35 47 81 97 47
Net Cash From Continuing Operating Activities
107 122 44 83 101 127 35 47 81 97 47
Net Income / (Loss) Continuing Operations
59 51 62 84 70 55 70 68 57 39 49
Consolidated Net Income / (Loss)
59 51 62 84 70 55 70 68 57 39 49
Depreciation Expense
18 18 16 17 17 17 17 19 22 25 24
Amortization Expense
- - - - - - 0.63 - - - 5.76
Non-Cash Adjustments To Reconcile Net Income
3.99 5.27 17 6.32 5.21 5.93 -0.30 5.13 3.28 5.43 3.89
Changes in Operating Assets and Liabilities, net
27 48 -51 -24 8.90 49 -52 -46 -0.20 27 -36
Net Cash From Investing Activities
-9.06 -20 -27 -10 -77 -91 -2.69 -96 -364 -18 -13
Net Cash From Continuing Investing Activities
-9.06 -20 -27 -10 -77 -91 -2.69 -96 -364 -18 -13
Purchase of Property, Plant & Equipment
-12 -19 -7.41 -9.02 -11 -25 -7.29 -9.18 -11 -20 -14
Sale of Property, Plant & Equipment
3.24 -0.57 0.37 0.24 2.84 0.35 4.61 0.13 -0.00 1.80 0.28
Net Cash From Financing Activities
-74 -78 -34 80 -5.71 -8.91 -13 -6.53 247 -114 786
Net Cash From Continuing Financing Activities
-74 -78 -34 80 -5.71 -8.91 -13 -6.53 247 -114 786
Repayment of Debt
-244 -192 -145 -705 0.58 -3.02 -7.09 -10 -96 -507 -338
Payment of Dividends
-4.65 -5.24 -3.64 -4.86 -6.28 -5.89 -6.03 -4.87 -7.98 -7.21 -7.21
Issuance of Debt
175 119 115 790 - - 0.00 8.67 351 401 1,131
Effect of Exchange Rate Changes
-16 -5.81 -9.44 -0.92 7.14 -31 22 - -4.83 1.98 -0.74

Annual Balance Sheets for ESAB

This table presents ESAB's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
3,461 3,754 3,829 4,034 4,766
Total Current Assets
964 989 998 1,148 1,262
Cash & Equivalents
41 72 102 249 186
Accounts Receivable
383 374 385 370 451
Inventories, net
420 417 393 404 482
Prepaid Expenses
52 57 62 56 66
Other Current Assets
67 69 56 69 77
Plant, Property, & Equipment, net
286 284 294 298 382
Total Noncurrent Assets
2,211 2,481 2,537 2,587 3,122
Goodwill
1,533 1,530 1,588 1,652 1,950
Intangible Assets
521 517 500 488 673
Other Noncurrent Operating Assets
156 434 449 447 500
Total Liabilities & Shareholders' Equity
3,461 3,754 3,829 4,034 4,766
Total Liabilities
960 2,366 2,181 2,226 2,555
Total Current Liabilities
597 602 620 632 665
Short-Term Debt
- - 0.00 15 2.41
Accounts Payable
345 316 307 318 360
Accrued Expenses
251 285 313 299 302
Total Noncurrent Liabilities
363 1,764 1,561 1,594 1,890
Long-Term Debt
0.00 1,219 1,018 1,061 1,233
Other Noncurrent Operating Liabilities
363 545 543 533 657
Total Equity & Noncontrolling Interests
2,502 1,388 1,648 1,808 2,212
Total Preferred & Common Equity
2,461 1,350 1,607 1,769 2,166
Total Common Equity
2,461 1,350 1,607 1,769 2,166
Common Stock
0.00 1,866 1,881 1,901 1,905
Retained Earnings
0.00 159 351 597 801
Accumulated Other Comprehensive Income / (Loss)
-461 -675 -624 -730 -540
Noncontrolling Interest
41 38 40 39 45

Quarterly Balance Sheets for ESAB

This table presents ESAB's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2023 6/30/2023 9/29/2023 3/29/2024 6/28/2024 9/27/2024 4/4/2025 7/4/2025 10/3/2025 4/3/2026
Total Assets
3,849 3,863 3,756 3,827 3,967 4,085 4,218 4,432 4,869 5,625
Total Current Assets
1,061 1,072 1,030 1,043 1,213 1,222 1,286 1,336 1,334 2,170
Cash & Equivalents
82 74 83 76 228 254 291 258 218 1,005
Accounts Receivable
404 413 388 430 431 421 415 456 460 488
Inventories, net
448 447 426 406 427 423 451 474 504 521
Prepaid Expenses
56 69 63 60 63 59 57 67 64 79
Other Current Assets
70 68 70 70 63 66 72 81 87 77
Plant, Property, & Equipment, net
284 282 276 290 287 296 307 327 358 377
Total Noncurrent Assets
2,505 2,509 2,450 2,494 2,467 2,567 2,624 2,769 3,178 3,077
Goodwill
1,564 1,586 1,554 1,587 1,584 1,668 1,685 1,790 1,963 1,931
Intangible Assets
518 505 491 484 477 500 503 542 684 656
Other Noncurrent Operating Assets
422 418 405 423 407 399 436 437 531 491
Total Liabilities & Shareholders' Equity
3,849 3,863 3,756 3,827 3,967 4,085 4,218 4,432 4,869 5,625
Total Liabilities
2,391 2,316 2,215 2,145 2,218 2,207 2,267 2,321 2,707 3,389
Total Current Liabilities
630 618 610 631 651 637 672 686 669 730
Short-Term Debt
- - - - - - 18 22 2.18 3.79
Accounts Payable
355 333 303 338 350 320 350 370 342 399
Accrued Expenses
275 285 308 293 301 317 305 295 325 328
Total Noncurrent Liabilities
1,760 1,698 1,605 1,514 1,567 1,570 1,595 1,634 2,038 2,659
Long-Term Debt
1,217 1,159 1,089 993 1,080 1,080 1,056 1,059 1,334 2,032
Other Noncurrent Operating Liabilities
544 539 515 521 487 490 539 575 704 627
Total Equity & Noncontrolling Interests
1,458 1,547 1,541 1,682 1,749 1,878 1,950 2,112 2,162 2,236
Total Preferred & Common Equity
1,420 1,506 1,501 1,641 1,708 1,837 1,910 2,070 2,116 2,191
Total Common Equity
1,420 1,506 1,501 1,641 1,708 1,837 1,910 2,070 2,116 2,191
Common Stock
1,868 1,873 1,876 1,882 1,886 1,894 1,902 1,899 1,901 1,905
Retained Earnings
188 250 304 407 485 548 660 720 769 842
Accumulated Other Comprehensive Income / (Loss)
-637 -617 -680 -648 -663 -605 -652 -550 -554 -557
Noncontrolling Interest
39 40 40 42 41 41 41 42 46 45

Annual Metrics And Ratios for ESAB

This table displays calculated financial ratios and metrics derived from ESAB's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - -
Revenue Growth
0.00% 24.51% 6.81% 6.99% -1.22% 3.71%
EBITDA Growth
0.00% 41.69% -7.28% 30.85% -8.77% 13.51%
EBIT Growth
0.00% 57.87% -5.90% 34.61% -8.35% 11.28%
NOPAT Growth
0.00% 45.91% 10.57% 11.71% 25.13% -8.10%
Net Income Growth
0.00% 49.30% -4.47% -7.45% 28.30% -13.86%
EPS Growth
0.00% 49.62% -5.87% -8.94% 28.27% -14.85%
Operating Cash Flow Growth
0.00% -18.90% -14.51% 54.18% 7.54% -26.68%
Free Cash Flow Firm Growth
0.00% 0.00% 108.01% 42.30% 11.33% -206.20%
Invested Capital Growth
0.00% 0.00% 3.03% 1.13% 2.77% 23.76%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.92% -0.67% 1.80%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 5.69% -13.89% -3.16%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 6.63% -15.77% -5.68%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 2.39% 1.39% -4.55%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -4.87% 1.30% -6.49%
EPS Q/Q Growth
0.00% 0.00% 0.00% -4.55% 0.94% -7.32%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 10.33% 1.28% -10.27%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 47.05% -27.91%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.63% -2.57% -0.59%
Profitability Metrics
- - - - - -
Gross Margin
35.00% 34.51% 34.14% 36.61% 37.85% 36.88%
EBITDA Margin
14.30% 16.27% 14.12% 17.27% 15.95% 17.46%
Operating Margin
10.37% 12.61% 12.69% 14.57% 16.33% 14.50%
EBIT Margin
10.37% 13.14% 11.58% 14.57% 13.51% 14.50%
Profit (Net Income) Margin
8.20% 9.83% 8.79% 7.61% 9.88% 8.21%
Tax Burden Percent
77.67% 74.80% 75.94% 66.13% 73.10% 71.05%
Interest Burden Percent
101.84% 100.00% 100.00% 78.95% 100.00% 79.64%
Effective Tax Rate
22.33% 25.20% 23.04% 30.00% 20.88% 21.07%
Return on Invested Capital (ROIC)
0.00% 18.62% 10.14% 11.10% 13.62% 11.04%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -28.12% 5.57% 4.13% 4.06% 1.22%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.46% 1.58% 2.80% 2.05% 0.57%
Return on Equity (ROE)
0.00% 19.08% 11.72% 13.90% 15.67% 11.60%
Cash Return on Invested Capital (CROIC)
0.00% -181.38% 7.15% 9.97% 10.89% -10.20%
Operating Return on Assets (OROA)
0.00% 9.22% 8.32% 10.66% 9.42% 9.37%
Return on Assets (ROA)
0.00% 6.90% 6.32% 5.57% 6.89% 5.30%
Return on Common Equity (ROCE)
0.00% 18.77% 11.48% 13.54% 15.31% 11.36%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.70% 16.89% 13.13% 15.31% 0.00%
Net Operating Profit after Tax (NOPAT)
157 229 253 283 354 325
NOPAT Margin
8.05% 9.43% 9.77% 10.20% 12.92% 11.45%
Net Nonoperating Expense Percent (NNEP)
0.00% 46.74% 4.57% 6.97% 9.56% 9.82%
Return On Investment Capital (ROIC_SIMPLE)
- - 9.71% 10.61% 12.28% 9.44%
Cost of Revenue to Revenue
65.00% 65.49% 65.86% 63.39% 62.15% 63.12%
SG&A Expenses to Revenue
23.52% 21.12% 20.57% 21.17% 21.15% 21.40%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.63% 21.90% 21.46% 22.04% 21.53% 22.38%
Earnings before Interest and Taxes (EBIT)
202 319 300 404 370 412
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
279 395 366 479 437 496
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.07 3.24 4.10 3.13
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 1.08 1.88 2.65 2.39
Price to Earnings (P/E)
0.00 0.00 12.51 25.36 27.38 29.91
Dividend Yield
0.00% 0.00% 0.32% 0.27% 0.25% 0.34%
Earnings Yield
0.00% 0.00% 7.99% 3.94% 3.65% 3.34%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.57 2.40 3.08 2.42
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 1.54 2.22 2.96 2.77
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 10.88 12.86 18.56 15.87
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 13.27 15.25 21.91 19.11
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 15.73 21.78 22.93 24.21
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 18.59 18.65 22.84 30.23
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 22.30 24.23 28.67 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.88 0.62 0.59 0.56
Long-Term Debt to Equity
0.00 0.00 0.88 0.62 0.59 0.56
Financial Leverage
0.00 -0.02 0.28 0.68 0.50 0.47
Leverage Ratio
0.00 1.38 1.85 2.50 2.28 2.19
Compound Leverage Factor
0.00 1.38 1.85 1.97 2.28 1.74
Debt to Total Capital
0.00% 0.00% 46.74% 38.19% 37.30% 35.83%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.52% 0.07%
Long-Term Debt to Total Capital
0.00% 0.00% 46.74% 38.19% 36.78% 35.76%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.64% 1.47% 1.51% 1.36% 1.32%
Common Equity to Total Capital
0.00% 98.36% 51.79% 60.30% 61.34% 62.85%
Debt to EBITDA
0.00 0.00 3.33 2.12 2.46 2.49
Net Debt to EBITDA
0.00 0.00 3.13 1.91 1.89 2.11
Long-Term Debt to EBITDA
0.00 0.00 3.33 2.12 2.43 2.48
Debt to NOPAT
0.00 0.00 4.81 3.60 3.04 3.80
Net Debt to NOPAT
0.00 0.00 4.53 3.24 2.33 3.22
Long-Term Debt to NOPAT
0.00 0.00 4.81 3.60 3.00 3.79
Altman Z-Score
0.00 0.00 1.85 2.75 3.30 2.86
Noncontrolling Interest Sharing Ratio
0.00% 1.64% 2.04% 2.59% 2.30% 2.11%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 1.62 1.64 1.61 1.82 1.90
Quick Ratio
0.00 0.71 0.74 0.79 0.98 0.96
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,231 179 254 283 -301
Operating Cash Flow to CapEx
894.28% 825.34% 605.63% 758.40% 740.82% 639.40%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 2.99 0.00 -3.58
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 3.88 0.00 3.11
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 3.37 0.00 2.62
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.70 0.72 0.73 0.70 0.65
Accounts Receivable Turnover
0.00 6.33 6.84 7.31 7.26 6.92
Inventory Turnover
0.00 3.79 4.08 4.34 4.28 4.05
Fixed Asset Turnover
0.00 8.48 9.09 9.59 9.25 8.36
Accounts Payable Turnover
0.00 4.60 5.16 5.65 5.45 5.29
Days Sales Outstanding (DSO)
0.00 57.65 53.33 49.96 50.31 52.75
Days Inventory Outstanding (DIO)
0.00 96.42 89.42 84.01 85.35 90.07
Days Payable Outstanding (DPO)
0.00 79.30 70.71 64.62 66.97 69.05
Cash Conversion Cycle (CCC)
0.00 74.77 72.04 69.34 68.68 73.76
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 2,461 2,535 2,564 2,635 3,261
Invested Capital Turnover
0.00 1.97 1.04 1.09 1.05 0.96
Increase / (Decrease) in Invested Capital
0.00 2,461 75 29 71 626
Enterprise Value (EV)
0.00 0.00 3,985 6,162 8,116 7,877
Market Capitalization
0.00 0.00 2,800 5,206 7,250 6,783
Book Value per Share
$0.00 $0.00 $22.43 $26.67 $29.26 $35.68
Tangible Book Value per Share
$0.00 $0.00 ($11.57) ($7.97) ($6.14) ($7.52)
Total Capital
0.00 2,502 2,607 2,666 2,884 3,446
Total Debt
0.00 0.00 1,219 1,018 1,076 1,235
Total Long-Term Debt
0.00 0.00 1,219 1,018 1,061 1,233
Net Debt
0.00 -41 1,147 916 826 1,049
Capital Expenditures (CapEx)
35 30 35 44 48 41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 326 315 276 282 414
Debt-free Net Working Capital (DFNWC)
0.00 367 387 378 531 600
Net Working Capital (NWC)
0.00 367 387 378 516 597
Net Nonoperating Expense (NNE)
-2.88 -9.63 25 72 83 92
Net Nonoperating Obligations (NNO)
0.00 -41 1,147 916 826 1,049
Total Depreciation and Amortization (D&A)
77 76 66 75 67 84
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 13.44% 12.15% 9.93% 10.29% 14.55%
Debt-free Net Working Capital to Revenue
0.00% 15.13% 14.93% 13.61% 19.39% 21.09%
Net Working Capital to Revenue
0.00% 15.13% 14.93% 13.61% 18.84% 21.01%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $3.70 $3.39 $4.36 $3.71
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 60.19M 60.34M 60.53M 60.73M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $3.69 $3.36 $4.31 $3.67
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 60.19M 60.34M 60.53M 60.73M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 60.19M 60.34M 60.53M 60.73M
Normalized Net Operating Profit after Tax (NOPAT)
174 243 271 300 362 347
Normalized NOPAT Margin
8.91% 10.02% 10.45% 10.80% 13.21% 12.22%
Pre Tax Income Margin
10.56% 13.14% 11.58% 11.50% 13.51% 11.55%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 4.75 0.00 4.91
NOPAT to Interest Expense
0.00 0.00 0.00 3.33 0.00 3.88
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 4.24 0.00 4.43
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 2.81 0.00 3.39
Payout Ratios
- - - - - -
Dividend Payout Ratio
2.69% 1.56% 4.16% 8.16% 7.63% 11.18%
Augmented Payout Ratio
2.69% 1.56% 4.16% 8.16% 7.63% 11.18%

Quarterly Metrics And Ratios for ESAB

This table displays calculated financial ratios and metrics derived from ESAB's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/29/2023 12/31/2023 3/29/2024 6/28/2024 9/27/2024 12/31/2024 4/4/2025 7/4/2025 10/3/2025 12/31/2025 4/3/2026
DEI Shares Outstanding
- - - - - - - - - - 60,728,709.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 60,728,709.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.78
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.79% 3.80% 0.84% -1.86% -1.14% -2.70% -1.68% 1.21% 8.11% 7.49% 9.95%
EBITDA Growth
18.77% 71.13% -13.10% 7.57% 3.74% 5.36% 10.84% -5.48% 4.38% -12.64% -6.14%
EBIT Growth
19.99% 92.73% -10.21% 9.86% 4.81% 7.43% 11.52% -8.60% 0.57% -22.27% -17.63%
NOPAT Growth
25.16% 10.76% 96.61% 18.55% 10.76% 6.60% 0.17% -12.42% -0.73% -18.26% -15.70%
Net Income Growth
10.87% -17.34% 85.43% 25.51% 18.13% 6.76% 13.37% -19.28% -19.06% -29.44% -29.49%
EPS Growth
9.30% -16.16% 88.46% 26.17% 18.09% 4.82% 12.24% -19.26% -18.92% -33.33% -29.09%
Operating Cash Flow Growth
35.06% 33.85% 16.81% 32.50% -5.90% 3.66% -20.37% -43.83% -19.36% -23.51% 32.49%
Free Cash Flow Firm Growth
0.00% 0.00% 103.13% 193.85% 97.08% -72.46% -161.02% -290.79% -582.06% -4,054.61% -846.93%
Invested Capital Growth
0.00% 1.13% 0.22% -1.17% 6.15% 2.77% 5.17% 12.83% 21.30% 23.76% 19.54%
Revenue Q/Q Growth
-5.47% 1.23% 0.06% 2.51% -4.78% -0.37% 1.10% 5.52% 1.71% -0.94% 3.41%
EBITDA Q/Q Growth
-6.06% 2.52% -19.62% 38.96% -9.41% 4.12% -0.67% 0.87% 0.04% -12.85% 7.25%
EBIT Q/Q Growth
-6.90% 2.54% -21.51% 46.62% -11.18% 5.10% -1.42% -0.68% -2.27% -18.76% 4.46%
NOPAT Q/Q Growth
-8.37% 4.49% 7.24% 15.45% -14.38% 0.56% 0.77% 0.94% -2.95% -17.20% 3.93%
Net Income Q/Q Growth
-12.06% -12.93% 19.67% 36.98% -17.23% -21.31% 27.08% -2.47% -17.01% -31.40% 26.98%
EPS Q/Q Growth
-12.15% -11.70% 18.07% 37.76% -17.78% -21.62% 26.44% -0.91% -17.43% -35.56% 34.48%
Operating Cash Flow Q/Q Growth
71.38% 13.99% -63.67% 86.69% 21.71% 25.57% -72.09% 31.68% 74.74% 19.12% -51.66%
Free Cash Flow Firm Q/Q Growth
-1,690.91% 102.07% 56.42% 62.05% -155.69% 119.51% -446.55% -406.66% -99.10% -13.12% 17.02%
Invested Capital Q/Q Growth
-3.18% 0.63% 1.36% 0.07% 3.99% -2.57% 3.74% 7.36% 11.79% -0.59% 0.20%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.67% 36.95% 36.97% 38.23% 37.70% 38.51% 37.63% 37.18% 37.00% 35.76% 36.90%
EBITDA Margin
17.43% 17.65% 14.18% 19.22% 18.29% 19.11% 18.78% 17.95% 17.66% 15.53% 16.11%
Operating Margin
14.85% 15.05% 16.04% 16.88% 15.75% 16.61% 16.20% 15.25% 14.65% 12.01% 12.14%
EBIT Margin
14.85% 15.05% 11.80% 16.88% 15.75% 16.61% 16.20% 15.25% 14.65% 12.01% 12.14%
Profit (Net Income) Margin
8.68% 7.47% 8.93% 11.93% 10.37% 8.19% 10.30% 9.52% 7.77% 5.38% 6.60%
Tax Burden Percent
73.30% 66.44% 75.66% 81.58% 78.36% 56.97% 75.04% 77.31% 68.07% 60.52% 75.86%
Interest Burden Percent
79.73% 74.70% 100.00% 86.64% 84.06% 86.57% 84.72% 80.75% 77.88% 73.97% 71.73%
Effective Tax Rate
24.56% 23.13% 22.73% 17.29% 20.28% 23.72% 22.03% 20.75% 21.31% 19.79% 20.20%
Return on Invested Capital (ROIC)
24.19% 12.59% 13.28% 14.77% 13.19% 13.36% 12.93% 11.95% 10.76% 9.29% 9.39%
ROIC Less NNEP Spread (ROIC-NNEP)
20.77% 9.85% 10.95% 13.29% 11.59% 9.91% 11.07% 9.76% 7.94% 6.02% 6.86%
Return on Net Nonoperating Assets (RNNOA)
13.56% 6.69% 7.15% 7.80% 6.21% 5.00% 5.18% 4.23% 3.82% 2.81% 2.97%
Return on Equity (ROE)
37.75% 19.28% 20.43% 22.57% 19.41% 18.36% 18.11% 16.18% 14.58% 12.10% 12.37%
Cash Return on Invested Capital (CROIC)
0.00% 9.97% 12.29% 14.21% 7.33% 10.89% 8.23% 0.29% -7.86% -10.20% -7.40%
Operating Return on Assets (OROA)
21.75% 11.01% 8.55% 11.93% 11.08% 11.58% 10.99% 9.94% 9.14% 7.76% 7.18%
Return on Assets (ROA)
12.71% 5.46% 6.47% 8.43% 7.30% 5.71% 6.99% 6.20% 4.84% 3.47% 3.91%
Return on Common Equity (ROCE)
36.76% 18.78% 19.90% 22.01% 18.95% 17.94% 17.70% 15.83% 14.27% 11.84% 12.11%
Return on Equity Simple (ROE_SIMPLE)
14.78% 0.00% 14.59% 15.02% 14.55% 0.00% 14.61% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
76 80 86 99 85 85 86 86 84 69 72
NOPAT Margin
11.20% 11.57% 12.40% 13.96% 12.55% 12.67% 12.63% 12.08% 11.53% 9.64% 9.68%
Net Nonoperating Expense Percent (NNEP)
3.42% 2.74% 2.33% 1.48% 1.60% 3.45% 1.86% 2.19% 2.82% 3.27% 2.53%
Return On Investment Capital (ROIC_SIMPLE)
- 2.99% - - - 2.95% 2.83% 2.71% 2.40% 2.02% 1.69%
Cost of Revenue to Revenue
63.33% 63.05% 63.03% 61.77% 62.30% 61.49% 62.37% 62.82% 63.00% 64.24% 63.10%
SG&A Expenses to Revenue
21.36% 20.98% 20.65% 20.68% 21.67% 21.65% 20.77% 21.74% 21.75% 21.31% 23.40%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.82% 21.91% 20.93% 21.35% 21.95% 21.90% 21.43% 21.93% 22.35% 23.74% 24.76%
Earnings before Interest and Taxes (EBIT)
101 104 81 119 106 111 110 109 107 87 90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
119 122 98 136 123 128 127 128 129 112 120
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.81 3.24 4.06 3.34 3.50 4.10 3.39 3.67 3.37 3.13 2.73
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.53 1.88 2.40 2.06 2.33 2.65 2.38 2.78 2.56 2.39 2.05
Price to Earnings (P/E)
19.56 25.36 28.57 22.76 24.63 27.38 23.81 29.68 29.38 29.91 28.85
Dividend Yield
0.31% 0.27% 0.22% 0.28% 0.26% 0.25% 0.30% 0.27% 0.31% 0.34% 0.41%
Earnings Yield
5.11% 3.94% 3.50% 4.39% 4.06% 3.65% 4.20% 3.37% 3.40% 3.34% 3.47%
Enterprise Value to Invested Capital (EV/IC)
2.07 2.40 2.93 2.54 2.70 3.08 2.67 2.89 2.53 2.42 2.16
Enterprise Value to Revenue (EV/Rev)
1.92 2.22 2.74 2.38 2.65 2.96 2.68 3.09 2.97 2.77 2.42
Enterprise Value to EBITDA (EV/EBITDA)
11.62 12.86 15.44 13.11 14.39 18.56 14.20 16.70 16.20 15.87 14.59
Enterprise Value to EBIT (EV/EBIT)
13.89 15.25 17.97 15.17 16.61 21.91 16.36 19.41 18.99 19.11 17.95
Enterprise Value to NOPAT (EV/NOPAT)
19.06 21.78 23.48 19.36 20.92 22.93 20.65 24.80 24.35 24.21 22.60
Enterprise Value to Operating Cash Flow (EV/OCF)
17.58 18.65 22.63 18.47 20.82 22.84 21.10 27.33 28.58 30.23 25.91
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 24.23 23.89 17.75 37.94 28.67 33.29 1,065.08 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.71 0.62 0.59 0.62 0.58 0.59 0.55 0.51 0.62 0.56 0.91
Long-Term Debt to Equity
0.71 0.62 0.59 0.62 0.58 0.59 0.54 0.50 0.62 0.56 0.91
Financial Leverage
0.65 0.68 0.65 0.59 0.54 0.50 0.47 0.43 0.48 0.47 0.43
Leverage Ratio
2.44 2.50 2.44 2.38 2.29 2.28 2.21 2.18 2.22 2.19 2.35
Compound Leverage Factor
1.94 1.87 2.44 2.06 1.93 1.97 1.88 1.76 1.73 1.62 1.69
Debt to Total Capital
41.41% 38.19% 37.11% 38.16% 36.52% 37.30% 35.51% 33.85% 38.20% 35.83% 47.67%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.52% 0.59% 0.68% 0.06% 0.07% 0.09%
Long-Term Debt to Total Capital
41.41% 38.19% 37.11% 38.16% 36.52% 36.78% 34.93% 33.17% 38.14% 35.76% 47.58%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.53% 1.51% 1.55% 1.47% 1.37% 1.36% 1.34% 1.32% 1.32% 1.32% 1.05%
Common Equity to Total Capital
57.06% 60.30% 61.33% 60.37% 62.11% 61.34% 63.14% 64.83% 60.48% 62.85% 51.28%
Debt to EBITDA
2.40 2.12 2.01 2.15 2.13 2.46 2.09 2.13 2.61 2.49 4.21
Net Debt to EBITDA
2.22 1.91 1.86 1.69 1.63 1.89 1.52 1.62 2.18 2.11 2.13
Long-Term Debt to EBITDA
2.40 2.12 2.01 2.15 2.13 2.43 2.05 2.09 2.60 2.48 4.21
Debt to NOPAT
3.94 3.60 3.06 3.17 3.09 3.04 3.04 3.16 3.92 3.80 6.53
Net Debt to NOPAT
3.64 3.24 2.82 2.50 2.37 2.33 2.21 2.41 3.28 3.22 3.31
Long-Term Debt to NOPAT
3.94 3.60 3.06 3.17 3.09 3.00 2.98 3.10 3.91 3.79 6.52
Altman Z-Score
2.21 2.49 2.94 2.68 2.87 3.09 2.84 3.07 2.61 2.64 2.15
Noncontrolling Interest Sharing Ratio
2.61% 2.59% 2.56% 2.48% 2.37% 2.30% 2.26% 2.17% 2.15% 2.11% 2.04%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.69 1.61 1.65 1.86 1.92 1.82 1.91 1.95 1.99 1.90 2.97
Quick Ratio
0.77 0.79 0.80 1.01 1.06 0.98 1.05 1.04 1.01 0.96 2.05
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,471 51 80 130 -72 14 -49 -247 -492 -557 -462
Operating Cash Flow to CapEx
1,244.10% 615.55% 631.10% 945.19% 1,297.05% 520.94% 1,316.85% 515.04% 728.71% 544.35% 349.38%
Free Cash Flow to Firm to Interest Expense
-120.54 1.95 0.00 8.12 -4.27 0.00 -2.91 -11.77 -20.86 -24.68 -18.06
Operating Cash Flow to Interest Expense
5.24 4.66 0.00 5.21 5.98 0.00 2.11 2.22 3.45 4.30 1.83
Operating Cash Flow Less CapEx to Interest Expense
4.82 3.91 0.00 4.66 5.52 0.00 1.95 1.79 2.98 3.51 1.31
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.46 0.73 0.72 0.71 0.70 0.70 0.68 0.65 0.62 0.65 0.59
Accounts Receivable Turnover
0.00 7.31 6.67 6.56 6.82 7.26 6.46 6.17 6.34 6.92 6.44
Inventory Turnover
0.00 4.34 4.12 3.98 4.07 4.28 3.95 3.78 3.76 4.05 3.79
Fixed Asset Turnover
0.00 9.59 9.68 9.73 9.64 9.25 9.13 8.92 8.53 8.36 8.50
Accounts Payable Turnover
0.00 5.65 5.07 5.09 5.54 5.45 4.92 4.74 5.26 5.29 4.92
Days Sales Outstanding (DSO)
0.00 49.96 54.76 55.66 53.53 50.31 56.50 59.15 57.61 52.75 56.65
Days Inventory Outstanding (DIO)
0.00 84.01 88.69 91.79 89.72 85.35 92.39 96.44 96.97 90.07 96.25
Days Payable Outstanding (DPO)
0.00 64.62 72.05 71.78 65.88 66.97 74.24 77.06 69.35 69.05 74.14
Cash Conversion Cycle (CCC)
0.00 69.34 71.40 75.67 77.38 68.68 74.65 78.53 85.23 73.76 78.75
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,548 2,564 2,599 2,601 2,704 2,635 2,733 2,934 3,280 3,261 3,267
Invested Capital Turnover
2.16 1.09 1.07 1.06 1.05 1.05 1.02 0.99 0.93 0.96 0.97
Increase / (Decrease) in Invested Capital
2,548 29 5.58 -31 157 71 134 334 576 626 534
Enterprise Value (EV)
5,266 6,162 7,624 6,598 7,305 8,116 7,307 8,470 8,300 7,877 7,050
Market Capitalization
4,219 5,206 6,666 5,706 6,438 7,250 6,483 7,605 7,136 6,783 5,974
Book Value per Share
$24.91 $26.67 $27.19 $28.27 $30.40 $29.26 $31.55 $34.14 $34.86 $35.68 $36.08
Tangible Book Value per Share
($9.04) ($7.97) ($7.13) ($5.83) ($5.47) ($6.14) ($4.59) ($4.33) ($8.75) ($7.52) ($6.52)
Total Capital
2,630 2,666 2,675 2,829 2,958 2,884 3,024 3,192 3,498 3,446 4,272
Total Debt
1,089 1,018 993 1,080 1,080 1,076 1,074 1,081 1,336 1,235 2,036
Total Long-Term Debt
1,089 1,018 993 1,080 1,080 1,061 1,056 1,059 1,334 1,233 2,032
Net Debt
1,006 916 916 851 827 826 783 822 1,118 1,049 1,031
Capital Expenditures (CapEx)
8.63 20 7.05 8.78 7.79 24 2.69 9.05 11 18 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
337 276 335 333 331 282 340 413 449 414 439
Debt-free Net Working Capital (DFNWC)
419 378 411 561 584 531 632 672 667 600 1,444
Net Working Capital (NWC)
419 378 411 561 584 516 614 650 665 597 1,440
Net Nonoperating Expense (NNE)
17 28 24 14 15 30 16 18 27 31 23
Net Nonoperating Obligations (NNO)
1,006 916 916 851 827 826 783 822 1,118 1,049 1,031
Total Depreciation and Amortization (D&A)
18 18 16 17 17 17 17 19 22 25 30
Debt-free, Cash-free Net Working Capital to Revenue
12.24% 9.93% 12.05% 12.03% 11.99% 10.29% 12.47% 15.10% 16.07% 14.55% 15.09%
Debt-free Net Working Capital to Revenue
15.25% 13.61% 14.80% 20.29% 21.18% 19.39% 23.15% 24.53% 23.88% 21.09% 49.62%
Net Working Capital to Revenue
15.25% 13.61% 14.80% 20.29% 21.18% 18.84% 22.50% 23.74% 23.80% 21.01% 49.49%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.95 $0.84 $0.99 $1.36 $1.12 $0.89 $1.10 $1.10 $0.90 $0.61 $0.78
Adjusted Weighted Average Basic Shares Outstanding
60.27M 60.34M 60.42M 60.44M 60.45M 60.53M 60.62M 60.70M 60.71M 60.73M 60.88M
Adjusted Diluted Earnings per Share
$0.94 $0.83 $0.98 $1.35 $1.11 $0.87 $1.10 $1.09 $0.90 $0.58 $0.78
Adjusted Weighted Average Diluted Shares Outstanding
60.27M 60.34M 60.42M 60.44M 60.45M 60.53M 60.62M 60.70M 60.71M 60.73M 60.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
60.27M 60.34M 60.42M 60.44M 60.45M 60.53M 60.62M 60.70M 60.71M 60.73M 60.88M
Normalized Net Operating Profit after Tax (NOPAT)
79 85 87 103 86 86 89 88 87 84 80
Normalized NOPAT Margin
11.55% 12.28% 12.61% 14.52% 12.78% 12.86% 13.15% 12.24% 12.00% 11.58% 10.77%
Pre Tax Income Margin
11.84% 11.24% 11.80% 14.63% 13.24% 14.38% 13.72% 12.31% 11.41% 8.89% 8.70%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.93 3.95 0.00 7.49 6.28 0.00 6.55 5.20 4.52 3.84 3.54
NOPAT to Interest Expense
3.72 3.04 0.00 6.19 5.00 0.00 5.10 4.12 3.56 3.08 2.82
EBIT Less CapEx to Interest Expense
4.51 3.19 0.00 6.94 5.81 0.00 6.39 4.76 4.05 3.05 3.01
NOPAT Less CapEx to Interest Expense
3.30 2.28 0.00 5.64 4.54 0.00 4.94 3.69 3.08 2.29 2.30
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
7.42% 8.16% 6.92% 7.17% 7.49% 7.63% 8.27% 8.78% 9.93% 11.18% 12.82%
Augmented Payout Ratio
7.42% 8.16% 6.92% 7.17% 7.49% 7.63% 8.27% 8.78% 9.93% 11.18% 12.82%

Financials Breakdown Chart

Key Financial Trends

Here are the notable trends for ESAB (NYSE: ESAB) based on the last four years of quarterly statements provided (2022–2025). The focus is on revenue, profitability, cash flow, and leverage trends that could impact investors.

  • Revenue rebound in Q4 2025: Operating revenue rose to $720.99 million, up from $664.13 million in Q4 2024, signaling a rebound after the 2024 dip.
  • Improving quarterly operating cash flow: Net cash from continuing operating activities reached $97.05 million in Q4 2025, up from $81.48 million in Q3 2025, showing sequential improvement in cash generation.
  • Healthy liquidity across 2025 quarters: Cash & equivalents hovered roughly in the $218–$291 million range across 2025 (Q3: $218.2M, Q1: $291.3M, Q2: $258.2M), indicating solid liquidity headroom.
  • Four-year revenue trend: Revenue declined from 2022 through 2024, then rebounded in 2025, highlighting volatility but a positive 2025 recovery.
  • Rising leverage: Long-term debt increased from about $1.06B in Q1 2025 to roughly $1.33B by Q3 2025, suggesting higher leverage and greater debt-servicing considerations.
  • Q4 2025 profitability declined vs. Q4 2024: Net income attributable to common shareholders fell to $37.67 million with diluted earnings per share of $0.58 in Q4 2025 (down from Q4 2024), indicating weaker quarterly profitability.
  • Cash balance and financing activity pressured in Q4 2025: Net change in cash and equivalents for Q4 2025 was a decrease of $32.36 million, with net cash from financing activities negative and sizable prior-period investing activity contributing to overall cash usage.
05/14/26 06:50 PM ETAI Generated. May Contain Errors.

ESAB Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ESAB's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

ESAB's net income appears to be on an upward trend, with a most recent value of $233.23 million in 2025, rising from $159.87 million in 2020. The previous period was $270.75 million in 2024. See ESAB's forecast for analyst expectations on what's next for the company.

ESAB's total operating income in 2025 was $412.17 million, based on the following breakdown:
  • Total Gross Profit: $1.05 billion
  • Total Operating Expenses: $636.17 million

Over the last 5 years, ESAB's total revenue changed from $1.95 billion in 2020 to $2.84 billion in 2025, a change of 45.8%.

ESAB's total liabilities were at $2.55 billion at the end of 2025, a 14.8% increase from 2024, and a 166.2% increase since 2021.

In the past 4 years, ESAB's cash and equivalents has ranged from $41.21 million in 2021 to $249.36 million in 2024, and is currently $185.86 million as of their latest financial filing in 2025.

Over the last 5 years, ESAB's book value per share changed from 0.00 in 2020 to 35.68 in 2025, a change of 3,567.8%.



Financial statements for NYSE:ESAB last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners